Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Smid

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Pharmacogenomics|August 13, 2015
Predicting paclitaxel-induced neutropenia using the DMET platformAnnemieke J M Nieuweboer, Marcel Smid, Anne-Joy M de Graan, et al.
Breast Cancer Research : BCR|December 10, 2025
APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive diseaseMaartje A C Schreurs, A Mieke Timmermans, Michael A Carpenter, et al.
Cancer Research|April 4, 2014
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwaysWim Verhaegh, Henk van Ooijen, Márcia A Inda, et al.
Breast Cancer Research and Treatment|October 24, 2007
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factorMatthias Kotzsch, Anieta M Sieuwerts, Marianne Grosser, et al.
Breast Cancer Research and Treatment|May 22, 2010
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancerF Germán Rodríguez-González, Anieta M Sieuwerts, Marcel Smid, et al.
Springerplus|November 7, 2015
Understanding drugs in breast cancer through drug sensitivity screeningKatharina Uhr, Wendy J C Prager-van der Smissen, Anouk A J Heine, et al.
Scientific Reports|April 1, 2021
Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapyEsmee Koedoot, Liesanne Wolters, Marcel Smid, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancerJohn A Foekens, Anieta M Sieuwerts, Marcel Smid, et al.
International Journal of Cancer|February 15, 2019
Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancerIngeborg E de Kruijff, Anieta M Sieuwerts, Wendy Onstenk, et al.
Cancers|June 27, 2019
Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAsAzadeh Amirnasr, Caroline M M Gits, Patricia F van Kuijk, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Pharmacogenomics|August 13, 2015
Predicting paclitaxel-induced neutropenia using the DMET platformAnnemieke J M Nieuweboer, Marcel Smid, Anne-Joy M de Graan, et al.
Breast Cancer Research : BCR|December 10, 2025
APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive diseaseMaartje A C Schreurs, A Mieke Timmermans, Michael A Carpenter, et al.
Cancer Research|April 4, 2014
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwaysWim Verhaegh, Henk van Ooijen, Márcia A Inda, et al.
Breast Cancer Research and Treatment|October 24, 2007
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factorMatthias Kotzsch, Anieta M Sieuwerts, Marianne Grosser, et al.
Breast Cancer Research and Treatment|May 22, 2010
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancerF Germán Rodríguez-González, Anieta M Sieuwerts, Marcel Smid, et al.
Springerplus|November 7, 2015
Understanding drugs in breast cancer through drug sensitivity screeningKatharina Uhr, Wendy J C Prager-van der Smissen, Anouk A J Heine, et al.
Scientific Reports|April 1, 2021
Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapyEsmee Koedoot, Liesanne Wolters, Marcel Smid, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancerJohn A Foekens, Anieta M Sieuwerts, Marcel Smid, et al.
International Journal of Cancer|February 15, 2019
Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancerIngeborg E de Kruijff, Anieta M Sieuwerts, Wendy Onstenk, et al.
Cancers|June 27, 2019
Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAsAzadeh Amirnasr, Caroline M M Gits, Patricia F van Kuijk, et al.
Pageof 13